Exelixis EXEL
NASDAQ EXEL
$58.39 +0.45 (+0.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Exelixis (EXEL) Asset Writedowns and Impairment (2025)

Updated

Exelixis (EXEL) reported Asset Writedowns and Impairment of $100,000 for Q4 2025.

Analysis

Exelixis (EXEL) Asset Writedowns and Impairment (2025) Analysis & Trends

For FY2025, Exelixis posted Asset Writedowns and Impairment of $64.4 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Exelixis 14.53 Bn 10.87 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jan 3, 2025 100,000.00
API Access

Exelixis Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=EXEL&period=max&api_key=YOUR_API_KEY